Navigation Links
Phreesia to Accelerate Growth with $16 Million Investment Led by Ascension Health Ventures
Date:5/25/2010

NEW YORK, May 25 /PRNewswire/ -- Phreesia, the leading patient check-in company, announced today the close of a $16 million Series D investment. Ascension Health Ventures (AHV) led the round, joining existing investors BlueCross BlueShield Venture Partners, L.P., Sandbox Industries, Polaris Venture Partners, HLM Venture Partners, and Long River Ventures. As part of the investment, Victor Kats, Investment Manager at Ascension Health Ventures, will be joining Phreesia's board of directors.

(Photo:  http://www.newscom.com/cgi-bin/prnh/20100525/NY07290 )

(Logo:  http://www.newscom.com/cgi-bin/prnh/20080220/NYW106LOGO )

"We're excited to have AHV leading this round. AHV is a strategic venture fund investing on behalf of four of the largest not-for-profit health systems in the country. Working with a fund like AHV that shares our mission to provide patient-centered care is important for Phreesia," said Phreesia's CEO and co-founder, Chaim Indig. "This investment will enable Phreesia to continue to expand its presence in the healthcare market so as to provide additional clinical value and increase revenue for clinicians across all 50 states."

Phreesia's technology platform automates the patient check-in process in thousands of physician offices and urgent care centers in the U.S. Its wireless touchscreen pads are used by patients to verify and update demographic and insurance information and provide valuable clinical information that seamlessly integrates into existing practice management and electronic health record systems. Physicians and other stakeholders are able to communicate and engage with patients at the time of care based on the medical condition(s) reported during the check-in process.

Victor Kats at AHV said, "This investment reinforces our belief that Phreesia is addressing a significant need for improved capture of clinical and demographic information at the point of care. By giving providers access to clinical tools that help meet emerging "meaningful use" requirements and that share vital patient information across venues of care, Phreesia is adding value for multiple stakeholders. We're proud to partner with an innovative and fast-growing healthcare company such as Phreesia."

Established in 2001 by Ascension Health, AHV closed a second fund in 2007 with $200 million in commitments from Ascension Health, Catholic Health East, Catholic Health Initiatives and Catholic Healthcare West. These health systems serve their communities through over 200 acute care hospitals and hundreds of outpatient facilities across 38 states and the District of Columbia.

About Ascension Health Ventures

Ascension Health Ventures was launched in 2001 as a wholly-owned subsidiary of Ascension Health. AHV's role has been to construct and manage a strategic portfolio of investments that deliver a venture investment return, have the potential to transform the healthcare industry and significantly enhance the quality of patient care. CHV II, LP, a limited partnership between Ascension Health, Catholic Health Initiatives, Catholic Health East and Catholic Healthcare West, has been formed to expand this strategic investment initiative to other Catholic healthcare systems. AHV is the general partner of CHV II, LP.

About Phreesia

Phreesia is the national leader in patient check-in. By automating patient intake, Phreesia allows medical practices to conveniently collect patient information and payments. Phreesia delivers fully interactive content direct-to-patients and is designed to interface with clinicians' existing and future technology. Phreesia is committed to enhancing the patient experience and enabling clinicians to stay at the forefront of patient care. For more information visit www.phreesia.com.


'/>"/>
SOURCE Phreesia
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Phreesia Announces Clinical Initiative to Better Manage Symptoms of Parkinsons Disease
2. GlaxoSmithKline Accelerates Review of Exelixis XL880
3. St. Jude Discovers Factors That Accelerate Resistance to Gleevec(TM) Targeted Therapy in Lymphoblastic Leukemia
4. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
5. Dr. Harriet Robinson Joins GeoVax Team as V.P. of R & D to Accelerate AIDS Vaccine Trials Program
6. Reduced Lung Capacity Accelerates With Diabetes
7. Breakthrough Large Scale Transfection Technology Accelerates Cell-Based Assay Development
8. World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research
9. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
10. Duke Licenses ALPHADAS(R), Logos Technologies EDC System to Accelerate its Early Phase Clinical Trials
11. Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2017)... Sept. 7, 2017   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade cell and tissue hypothermic storage ... Mike Rice , President and CEO, will be presenting ... Rodman & Renshaw 19 th Annual Global Investment ... (12:25 p.m. Pacific time). The conference is being held at ...
(Date:9/6/2017)... INDIANAPOLIS , Sept. 6, 2017 Eli ... today it will present new data for galcanezumab and ... Congress of the International Headache Society (IHC) taking place ... Lilly will highlight new, long-term data from ... two doses of galcanezumab (120 mg and 240 mg) ...
(Date:9/5/2017)... JERUSALEM , Sept. 5, 2017 Oramed Pharmaceuticals ... www.oramed.com ), a clinical-stage pharmaceutical company focused on the ... it has successfully concluded its meeting with the U.S. ... novel oral insulin formulation. ... that the regulatory pathway for submission of ORMD-0801, would ...
Breaking Medicine Technology:
(Date:9/19/2017)... ... September 19, 2017 , ... Public outrage over the toxins that exist ... deaf ears, leaving the water industry itself to research, develop and ultimately supply consumers ... curve in the field of natural alkaline water technologies, water filtration ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... the launch of its magnesium-based orthopedic medical device, OsteoCrete®. OsteoCrete® bone void filler ... in the U.S. to incorporate magnesium, a critical property for bone health and ...
(Date:9/19/2017)... (PRWEB) , ... September 19, 2017 , ... Ron Norman, ... candidates today the importance of making a distinct rather than generic impression in the ... had to look through a stack of resumes knows that the first impression they ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... to the Certified Emergency Nurse (CEN®) certification according to a large-scale ... value of certification study, conducted by the Human Resources Research Organization (HumRRO) in ...
(Date:9/18/2017)... , ... September 18, 2017 , ... A September 7 ... in Belfast indicating that aspirin, one of the world’s most common and least expensive ... Los Angeles area dentist Dr. Farzad Feiz of California Dental Group and Calabasas Dental ...
Breaking Medicine News(10 mins):